Edit Entry | Edit CV

Laura J. Tafe, MD

Title(s)
Associate Professor of Pathology and Laboratory Medicine

Additional Titles/Positions/Affiliations
Assistant Director, Laboratory for Clinical Genomics and Advanced Technology (CGAT), Dartmouth-Hitchcock Medical Center

Department(s)
Pathology and Laboratory Medicine

Education
Medical School:
MD, Wayne State University School of Medicine, Detroit, MI, 2004

Residency:
Dartmouth-Hitchcock Medical Center, Lebanon, NH, Anatomic and Clinical Pathology, 2004-08

Fellowship:
Memorial Sloan-Kettering Cancer Center, New York, NY, Oncologic Pathology, 2008-09

Fellowship:
Memorial Sloan-Kettering Cancer Center, New York, NY, Diagnostic Molecular Pathology, 2009-10

Board Certification:
Anatomic and Clinical Pathology, 2008
Molecular Genetic Pathology, 2011

Websites
http://cancer.dartmouth.edu/lung_thoracic/teamprofile/56703/Laura_J_Tafe_MD

Academic Analytics
View Profile

Contact Information

Department of Pathology
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon NH 03756


Selected Publications

 

Deep Learning for Grading Endometrial Cancer.
Goyal M, Tafe LJ, Feng JX, Muller KE, Hondelink L, Bentz JL, Hassanpour S
Am J Pathol. 2024 Jun 13; pii: S0002-9440(24)00202-5. doi: 10.1016/j.ajpath.2024.05.003. Epub 2024 Jun 13.
PMID: 38879079

Does ROSE matter? Evaluation of final diagnostic, PD-L1 immunohistochemistry, and molecular testing yields of CT-guided lung biopsies performed before and after the onset of the COVID-19 pandemic.
Jennings EB, Percarpio RB, Tafe LJ, Demidenko E, Levy J, Gutmann EJ, Marotti JD
J Am Soc Cytopathol. 2024 Mar 29; pii: S2213-2945(24)00024-3. doi: 10.1016/j.jasc.2024.03.004. Epub 2024 Mar 29.
PMID: 38677893

A Pineal Parenchymal Tumor of Intermediate Differentiation in an Octogenarian Contains a Rare KBTBD4 Insertion.
Jones VM, Kanter JH, Russo GA, Simmons NE, Tafe LJ, Zanazzi GJ
Int J Surg Pathol. 2023 Oct 19;:10668969231201411. doi: 10.1177/10668969231201411. Epub 2023 Oct 19.
PMID: 37855103

Recommendations for Cell-Free DNA Assay Validations: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.
Lockwood CM, Borsu L, Cankovic M, Earle JSL, Gocke CD, Hameed M, Jordan D, Lopategui JR, Pullambhatla M, Reuther J, Rumilla KM, Tafe LJ, Temple-Smolkin RL, Terraf P, Tsimberidou AM
J Mol Diagn. 2023 Dec;25(12):876-897. doi: 10.1016/j.jmoldx.2023.09.004. Epub 2023 Oct 6.
PMID: 37806433

RNA Sequencing for Solid Tumor Fusion Gene Detection: Proficiency Testing Practice and Performance Comparison.
Bridge JA, Halling KC, Moncur JT, Souers RJ, Hameed MR, Fernandes H, Roy A, Surrey L, Tafe LJ, Vasalos P, Lopez-Terrada DH
Arch Pathol Lab Med. 2024 May 1;148(5):538-544. doi: 10.5858/arpa.2023-0047-CP.
PMID: 37535666

Cutaneous myoepithelioma with EWSR1 gene rearrangement and its differentials: A diagnostic challenge.
Okorie CL, Yan S, Kerr DA, Tafe LJ, Sriharan A
J Cutan Pathol. 2023 Jul;50(7):632-636. doi: 10.1111/cup.14433. Epub 2023 Apr 14.
PMID: 37057381

Utility of Retrospective Molecular Analysis in Diagnostically Challenging Mesenchymal Neoplasms.
Mindiola Romero AE, Tafe LJ, Green DC, Deharvengt SJ, Winnick KN, Tsongalis GJ, Baker ML, Linos K, Levy JJ, Kerr DA
Int J Surg Pathol. 2023 Dec;31(8):1473-1484. doi: 10.1177/10668969231157783. Epub 2023 Mar 13.
PMID: 36911994

Fluorescence molecular optomic signatures improve identification of tumors in head and neck specimens.
Chen Y, Streeter SS, Hunt B, Sardar HS, Gunn JR, Tafe LJ, Paydarfar JA, Pogue BW, Paulsen KD, Samkoe KS
Front Med Technol. 2023;5:1009638. doi: 10.3389/fmedt.2023.1009638. Epub 2023 Feb 15.
PMID: 36875185

Current Laboratory Testing Practices for Assessment of ERBB2/HER2 in Endometrial Serous Carcinoma and Colorectal Carcinoma.
Hagemann IS, Bridge JA, Tafe LJ, Hameed MR, Moncur JT, Bellizzi AM, Dolan M, Vasalos P, Kane ME, Souers RJ, Yemelyanova A
Arch Pathol Lab Med. 2023 Oct 1;147(10):1148-1157. doi: 10.5858/arpa.2022-0229-CP.
PMID: 36538387

Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma.
Brown LC, Zhu J, Desai K, Kinsey E, Kao C, Lee YH, Pabla S, Labriola MK, Tran J, Dragnev KH, Tafe LJ, Dayyani F, Gupta RT, McCall S, George DJ, Glenn ST, Nesline MK, George S, Zibelman M, Morrison C, Ornstein MC, Zhang T
J Immunother Cancer. 2022 Oct;10(10) doi: 10.1136/jitc-2022-005249.
PMID: 36252996

View more publications on PubMed